Mediclinic sees higher FY revenues as strong performance continues
By Iain Gilbert
Date: Thursday 12 Dec 2019
(Sharecast News) - Private healthcare group Mediclinic said it expected expects full-year revenues to grow by around 6.5% as its strong first half performance continued.
Mediclinic added that its earnings before interest, tax, depreciation and amortisation (EBITDA) margin remained unchanged.
As a result of higher staffing levels, together with an expected lower margin contribution from the Intercare business and the ramp-up of its new Stellenbosch facility, Mediclinic anticipated a full-year EBITDA margin of around 20%.
As of 0840 GMT, Mediclinic shares were up 1.04% to 388.90p.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN